Pentwater Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$925K 138
2019
Q4
$925K Sell
10,000
-170,000
-94% -$14.9M 0.02% 105
2019
Q3
$16.3M Buy
+180,000
New +$20.5M 0.25% 49

Other funds holding EXAS

Pentwater Capital Management's EXAS Position: Q1 2026 in Review

Pentwater Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,250,000 shares — an estimated $736M sold.

Pentwater Capital Management first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $736M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Pentwater Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Pentwater Capital Management sold 7,250,000 Exact Sciences shares in Q1 2026, an estimated $736M.
  • Pentwater Capital Management first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
  • Pentwater Capital Management's Exact Sciences position peaked at $736M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Pentwater Capital Management's 13F filing for Q1 2026, filed 15 May 2026.